{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:37:56Z","timestamp":1792467476697,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010983","name":"Health Research Fund of Central Denmark Region","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010983","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jaci.2020.07.002","type":"journal-article","created":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T04:00:59Z","timestamp":1594785659000},"page":"1011-1019","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Intralymphatic immunotherapy improves grass pollen allergic rhinoconjunctivitis: A\u00a03-year randomized placebo-controlled trial"],"prefix":"10.1016","volume":"147","author":[{"given":"S\u00f8ren Helbo","family":"Skaarup","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes Martin","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Skjold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Graumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans J\u00fcrgen","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2020.07.002_bib1","article-title":"Allergen injection immunotherapy for seasonal allergic rhinitis","volume":"2007","author":"Calderon","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaci.2020.07.002_bib2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jaci.2013.03.013","article-title":"Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy","volume":"132","author":"Kiel","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.07.002_bib3","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1111\/all.13135","article-title":"Novel approaches and perspectives in allergen immunotherapy","volume":"72","author":"Hoffmann","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2020.07.002_bib4","doi-asserted-by":"crossref","first-page":"17908","DOI":"10.1073\/pnas.0803725105","article-title":"Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial","volume":"105","author":"Senti","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2020.07.002_bib5","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jaci.2012.10.056","article-title":"Intralymphatic allergen-specific immunotherapy: an effective and safe alternative treatment route for pollen-induced allergic rhinitis","volume":"131","author":"Hylander","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.07.002_bib6","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.jaci.2013.07.033","article-title":"Is intralymphatic immunotherapy ready for clinical use in patients with grass pollen allergy?","volume":"132","author":"Witten","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.07.002_bib7","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jaci.2014.04.029","article-title":"Early improvement in basophil sensitivity predicts symptom relief with grass pollen immunotherapy","volume":"134","author":"Schmid","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.07.002_bib8","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/all.12383","article-title":"Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper","volume":"69","author":"Pfaar","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2020.07.002_bib9","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/all.13092","article-title":"Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis \u2013 an EAACI position paper","volume":"72","author":"Pfaar","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2020.07.002_bib10","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1111\/all.13487","article-title":"New European Academy of Allergy and Clinical Immunology definition on pollen season mirrors symptom load for grass and birch pollen-induced allergic rhinitis","volume":"73","author":"Karatzas","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2020.07.002_bib11","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jaci.2005.12.1358","article-title":"Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis","volume":"117","author":"Durham","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.07.002_bib12","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1111\/all.12513","article-title":"A high polymerized grass pollen extract is efficacious and safe in a randomized double-blind, placebo-controlled study using a novel up-dosing cluster-protocol","volume":"69","author":"Klimek","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2020.07.002_bib13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1398-9995.2006.01312.x","article-title":"Recommendations for standardization of clinical trials with allergen specific immunotherapy for respiratory allergy: a statement of a World Allergy Organization (WAO) taskforce","volume":"62","author":"Canonica","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2020.07.002_bib14","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jaci.2011.12.973","article-title":"SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial","volume":"129","author":"Durham","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.07.002_bib15","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1398-9995.2010.02434.x","article-title":"Days with severe symptoms: an additional efficacy endpoint in immunotherapy trials","volume":"66","author":"Durham","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2020.07.002_bib16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000493647","article-title":"Intralymphatic immunotherapy: update and unmet needs","volume":"178","author":"Senti","year":"2019","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2020.07.002_bib17","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.jaci.2019.11.017","article-title":"Intralymphatic immunotherapy in pollen allergic young adults with rhinoconjunctivitis and mild asthma: a randomized trial","volume":"145","author":"Konradsen","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.07.002_bib18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12931-016-0324-9","article-title":"Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trial","volume":"17","author":"Hylander","year":"2016","journal-title":"Respir Res"},{"key":"10.1016\/j.jaci.2020.07.002_bib19","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jaci.2012.02.026","article-title":"Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections","volume":"129","author":"Senti","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.07.002_bib20","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.anai.2015.11.010","article-title":"Three-injection intralymphatic immunotherapy in adolescents and young adults with grass pollen rhinoconjunctivitis","volume":"116","author":"Patterson","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2020.07.002_bib21","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.jaci.2018.05.030","article-title":"Intralymphatic immunotherapy with 2 concomitant allergens, birch and grass: a randomized, double-blind, placebo-controlled trial","volume":"142","author":"Hellkvist","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.07.002_bib22","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jaci.2013.11.036","article-title":"Intralymphatic immunotherapy: time interval between injections is essential","volume":"133","author":"K\u00fcndig","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.07.002_bib23","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1016\/j.jaci.2017.12.999","article-title":"Comparison of allergy immunotherapy medication persistence with a sublingual immunotherapy tablet versus subcutaneous immunotherapy in Germany","volume":"141","author":"Allam","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.07.002_bib24","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/ACI.0b013e328332b8df","article-title":"Evidence of adherence to allergen-specific immunotherapy","volume":"9","author":"Senna","year":"2009","journal-title":"Curr Opin Allergy Clin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674920309647?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674920309647?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:31:44Z","timestamp":1758792704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674920309647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0091674920309647"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2020.07.002","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intralymphatic immunotherapy improves grass pollen allergic rhinoconjunctivitis: A\u00a03-year randomized placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2020.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}